Proctosedyl (suppositories): Supply issue

Supply issue Section 29A Active

Unfortunately, AFT (the supplier) has run out of Proctosedyl suppositories (Pharmacode: 208396)

7 May 2026 | Some stock available

The supplier advises that a shipment of Proctosedyl suppositories (Pharmacode: 208396) has arrived and is available for wholesalers to order. It will take another 1 to 2 weeks to reach pharmacies around the country. 

Where Proctosedyl suppositories are not available, Scheriproct is a funded alternative. 

Affected product

An expected shipment has been delayed. This has resulted in a supplier out of stock of the following product:

  • Chemical: Hydrocortisone with cinchocaine
  • Presentation: Suppos Hydrocortisone 5 mg with cinchocaine hydrochloride 5 mg per g
  • Brand: Proctosedyl
  • Pharmacode: 208396
  • Subsidy: $9.90
  • Measure / Qty: per 12

There are only limited amounts still available at wholesalers. 

Schedule listings for Proctosedyl(external link)

Alternative product

The Proctosedyl ointment (Pharmacode: 208388) is available. There is a supply issue affecting Ultraproct suppositories which treat the same issues as Proctosedyl. 

Ultraproct supply issue

Alternative listed from 12 March 2026

Scheriproct was funded from 12 March 2026. Please note that it has a different mix of chemicals than Proctosedyl or Ultraproct. It has not been registered with Medsafe so needs to be prescribed and dispensed in line with section 29 of the Medicines Act.

  • Chemical: Prednisolone hexanoate with cinchocaine hydrochloride
  • Presentation: Suppos Prednisolone hexanoate 1.3 mg with cinchocaine hydrochloride 1 mg per g
  • Brand: Scheriproct
  • Pharmacode: 2725509
  • Subsidy: $8.61
  • Measure / Qty: per 12

Section 29 and wastage apply

Schedule listing for Scheriproct(external link)

Prescribing and supplying an unapproved medicine

Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people by their usual prescriber. Section 29A still applies even though the chemical is not identical because Scheriproct was listed to cover a supply issue.

We know supplying an unapproved medicine is not ideal. In this case, however, this will allow people to continue to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Prescriber and pharmacist requirements for section 29 and 29A medicines – Medsafe website (external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Some stock arrived April 2026

AFT, the supplier, advises a shipment has arrived and is available to order. It can take another 1 to 2 weeks to reach pharmacies around the country. 

We are continuing to monitor this situation until stock levels have returned to normal levels.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)